These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16398004)

  • 1. Improving treatment adherence in drug abusers who are HIV-positive.
    Malone SB; Osborne JJ
    Lippincotts Case Manag; 2000; 5(6):236-45; quiz 245-7. PubMed ID: 16398004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance/adherence and care management in HIV disease.
    Crespo-Fierro M
    J Assoc Nurses AIDS Care; 1997; 8(4):43-54. PubMed ID: 9260150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.
    Celentano DD; Lucas G
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S318-23. PubMed ID: 18190306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.
    Arnsten JH; Demas PA; Grant RW; Gourevitch MN; Farzadegan H; Howard AA; Schoenbaum EE
    J Gen Intern Med; 2002 May; 17(5):377-81. PubMed ID: 12047736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.
    Hinkin CH; Hardy DJ; Mason KI; Castellon SA; Durvasula RS; Lam MN; Stefaniak M
    AIDS; 2004 Jan; 18 Suppl 1(Suppl 1):S19-25. PubMed ID: 15075494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the HIV/AIDS case manager: analysis of a case management adherence training and coordination program in North Carolina.
    Shelton RC; Golin CE; Smith SR; Eng E; Kaplan A
    AIDS Patient Care STDS; 2006 Mar; 20(3):193-204. PubMed ID: 16548716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A programme of symptom management for improving quality of life and drug adherence in AIDS/HIV patients.
    Chiou PY; Kuo BI; Lee MB; Chen YM; Chuang P; Lin LC
    J Adv Nurs; 2006 Jul; 55(2):169-79. PubMed ID: 16866809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China.
    Wang X; Wu Z
    AIDS; 2007 Dec; 21 Suppl 8():S149-55. PubMed ID: 18172384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug use and medication adherence among HIV-1 infected individuals.
    Hinkin CH; Barclay TR; Castellon SA; Levine AJ; Durvasula RS; Marion SD; Myers HF; Longshore D
    AIDS Behav; 2007 Mar; 11(2):185-94. PubMed ID: 16897351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of illicit drug use and substance abuse treatment on adherence to HAART.
    Hicks PL; Mulvey KP; Chander G; Fleishman JA; Josephs JS; Korthuis PT; Hellinger J; Gaist P; Gebo KA;
    AIDS Care; 2007 Oct; 19(9):1134-40. PubMed ID: 18058397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
    Chander G; Himelhoch S; Moore RD
    Drugs; 2006; 66(6):769-89. PubMed ID: 16706551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.
    Lucas GM
    Life Sci; 2011 May; 88(21-22):948-52. PubMed ID: 20888839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.
    Joseph B; Kerr T; Puskas CM; Montaner J; Wood E; Milloy MJ
    AIDS Care; 2015; 27(9):1128-36. PubMed ID: 25915438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of use of alcohol and illicit drugs by AIDS patients on adherence to antiretroviral therapy in Bahia, Brazil.
    Teixeira C; Dourado Mde L; Santos MP; Brites C
    AIDS Res Hum Retroviruses; 2013 May; 29(5):799-804. PubMed ID: 23294471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.